Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Journal of Medicinal Chemistry
|
November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
John R Horton, Clayton B Woodcock, Qin Chen, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Cell Reports
|
November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer
Benedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Nature
|
April 22, 2015
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Fadi J Najm, Mayur Madhavan, Anita Zaremba, et al.
Cell Chemical Biology
|
July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds
John R Horton, Xu Liu, Molly Gale, et al.
Plos Biology
|
August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu, Jian Cao, Wesley L Cai, et al.
Plos One
|
July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Jonathan A Lee, Paul Shinn, Susan Jaken, et al.
Cell Reports
|
April 28, 2021
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome
Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, et al.
Scientific Reports
|
October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Daniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenase
Plamen P Christov, Kwangho Kim, Somnath Jana, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Journal of Medicinal Chemistry
|
November 6, 2018
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A
John R Horton, Clayton B Woodcock, Qin Chen, et al.
Cancer Research
|
March 21, 2020
Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer
Koen D Flach, Manikandan Periyasamy, Ajit Jadhav, et al.
Cell Reports
|
November 21, 2024
ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer
Benedetto DiCiaccio, Marco Seehawer, Zheqi Li, et al.
Nature
|
April 22, 2015
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Fadi J Najm, Mayur Madhavan, Anita Zaremba, et al.
Cell Chemical Biology
|
July 19, 2016
Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds
John R Horton, Xu Liu, Molly Gale, et al.
Plos Biology
|
August 7, 2018
KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu, Jian Cao, Wesley L Cai, et al.
Plos One
|
July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays
Jonathan A Lee, Paul Shinn, Susan Jaken, et al.
Cell Reports
|
April 28, 2021
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome
Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, et al.
Scientific Reports
|
October 8, 2017
Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays
Daniel J Urban, Natalia J Martinez, Mindy I Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2021
Optimization of ether and aniline based inhibitors of lactate dehydrogenase
Plamen P Christov, Kwangho Kim, Somnath Jana, et al.
Page
of 17